Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 172

1.
2.

Antisense to transforming growth factor-beta1 messenger RNA reduces vein graft intimal hyperplasia and monocyte chemotactic protein 1.

Wolff RA, Ryomoto M, Stark VE, Malinowski R, Tomas JJ, Stinauer MA, Hullett DA, Hoch JR.

J Vasc Surg. 2005 Mar;41(3):498-508.

3.

Antisense to transforming growth factor-beta(1) facilitates the apoptosis of macrophages in rat vein grafts.

Heaton NS, Wolff RA, Malinowski RL, Hullett DA, Hoch JR.

J Vasc Res. 2008;45(5):365-74. doi: 10.1159/000121406. Epub 2008 Mar 20.

PMID:
18354256
4.

[Expression of early growth response gene-1 and its correlative genes in autogenous vein graft and significance thereof: an experiment with rats].

Liu CW, Hu XH, Yang J, Zhang Q, Zhang XS, Duan ZQ.

Zhonghua Yi Xue Za Zhi. 2005 Dec 21;85(48):3414-8. Chinese.

PMID:
16409863
5.

Macrophage depletion reduces monocyte chemotactic protein-1 and transforming growth factor-beta1 in healing rat vein grafts.

Wolff RA, Tomas JJ, Hullett DA, Stark VE, van Rooijen N, Hoch JR.

J Vasc Surg. 2004 Apr;39(4):878-88.

6.

Vein adaptation to arterialization in an experimental model.

Westerband A, Crouse D, Richter LC, Aguirre ML, Wixon CC, James DC, Mills JL, Hunter GC, Heimark RL.

J Vasc Surg. 2001 Mar;33(3):561-9.

7.
8.

Transforming growth factor-beta1 expression and the role of angiotensin-converting enzyme inhibitor on perianastomotic intimal hyperplasia in polytetrafluoroethylene graft implanted in rabbit carotid artery.

Um JW, Kim JM, Min BW, Kim YS, Son GS, Lee JB, Jung SI, Kim SJ, Choi SY, Koo BH, Ishibashi N, Shirouzu K, Whang CW.

Kurume Med J. 2004;51(3-4):235-43.

9.

Differential expression and activity of matrix metalloproteinases during flow-modulated vein graft remodeling.

Berceli SA, Jiang Z, Klingman NV, Pfahnl CL, Abouhamze ZS, Frase CD, Schultz GS, Ozaki CK.

J Vasc Surg. 2004 May;39(5):1084-90.

10.

Intimal hyperplasia and expression of transforming growth factor-beta1 in saphenous veins and internal mammary arteries before coronary artery surgery.

Friedl R, Li J, Schumacher B, Hanke H, Waltenberger J, Hannekum A, Stracke S.

Ann Thorac Surg. 2004 Oct;78(4):1312-8.

PMID:
15464491
11.

[Influence of recombinant transforming growth factor-beta3 on collagen synthesis and deposition: experiment with rat cell model of liver fibrosis].

Li Q, Zhou X, Yu J, Qian W, Xu KS.

Zhonghua Yi Xue Za Zhi. 2008 May 13;88(18):1273-8. Chinese.

PMID:
18844103
12.

Nanoparticle-mediated local delivery of an antisense TGF-β1 construct inhibits intimal hyperplasia in autogenous vein grafts in rats.

Sun DX, Liu Z, Tan XD, Cui DX, Wang BS, Dai XW.

PLoS One. 2012;7(7):e41857. doi: 10.1371/journal.pone.0041857. Epub 2012 Jul 30.

13.
14.
15.
16.
17.

Adenovirus-mediated gene transfer of transforming growth factor-beta3, but not transforming growth factor-beta1, inhibits constrictive remodeling and reduces luminal loss after coronary angioplasty.

Kingston PA, Sinha S, Appleby CE, David A, Verakis T, Castro MG, Lowenstein PR, Heagerty AM.

Circulation. 2003 Dec 2;108(22):2819-25. Epub 2003 Nov 24.

18.

Adenoviral-mediated expression of antisense RNA to basic fibroblast growth factor reduces tangential stress in arterialized vein grafts.

Hanna AK, Durán WN, Leconte I, Fox JC, Neschis DG, Hobson RW 2nd, Golden MA.

J Vasc Surg. 2000 Apr;31(4):770-80.

19.

Significance of changes in transforming growth factor-beta mRNA levels in autogenous vein grafts.

You WJ, Xiao MD, Yuan ZX.

Chin Med J (Engl). 2004 Jul;117(7):1060-5.

PMID:
15265383
20.

Immunolocalization and temporal distribution of cytokine expression during the development of vein graft intimal hyperplasia in an experimental model.

Faries PL, Marin ML, Veith FJ, Ramirez JA, Suggs WD, Parsons RE, Sanchez LA, Lyon RT.

J Vasc Surg. 1996 Sep;24(3):463-71.

Supplemental Content

Support Center